BioSpace News Archive

Adare Pharma Solutions, a technology-driven contract development and manufacturing organization, announced the acquisition of Frontida BioPharm, a vertically integrated CDMO focused on oral formulations.

Eli Lilly and Company (NYSE: LLY) announced today that it will host a meeting for the investment community on Wednesday, Dec. 15, 2021, from 9 a.m. to 4 p.m., Eastern time.

MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021.

Cellevolve Bio (“the Company” or “Cellevolve”), a development and commercialization company focused on cell therapies, today announced a broad-based collaboration with Australia-based QIMR Berghofer Medical Research Institute and its cell therapy manufacturing facility Q-Gen Cell Therapeutics.

Paragonix Technologies, the leading hypothermic donor organ preservation provider, announced the first-in-human clinical use of the investigational NRP-DCD Method by the University of Nebraska Medical Center to recover a donor heart and transport it utilizing the Paragonix SherpaPak® System.

Aether Biomachines, a leading enzyme engineering company building a future of abundance, announced the appointment of Austin Che to its Board of Directors.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that BREXAFEMME® (ibrexafungerp tablets) has been named as a Popular Science 2021 “Best of What’s New” award winner in the Health category.

In a line of dominos, if you take out a single piece, the last one will never fall. Similarly, a lot of pieces have to line up and be pushed at the same time in a cell to result in cancer.

FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the establishment of an Innovation and Collaboration Center in Suzhou New District, China.

At the World Nuclear Exhibition today, Westinghouse Electric Company and EDF signed a historic Memorandum of Understanding (MoU) to produce Cobalt-60 radioisotope in select Pressurized Water Reactors (PWR) owned and operated by EDF in France.